Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-09-16Clinical Trial Update: BMS-790052 (Daclatasvir) Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis C [Phase 3]
Phase 3 clinical trial evaluating daclatasvir in combination with peg-interferon alfa-2a and ribavirin in treatment-naive patients with Hepa…
-
CLINICAL_TRIALS trial_result · 2015-09-16Clinical Trial Update: Study to Assess the Effect of BMS-790052 on the Pharmacokinetics of Ortho Tri-Cyclen® in Healthy Female Subjects [Phase 1]
Phase 1 pharmacokinetic interaction study to evaluate how daclatasvir (BMS-790052) affects the plasma levels of Ortho Tri-Cyclen in healthy …
-
CLINICAL_TRIALS trial_result · 2015-09-14Clinical Trial Update: Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV [Phase 3]
Phase III trial evaluating the combination of daclatasvir and sofosbuvir for genotype 3 chronic hepatitis C completed with results posted in…
-
CLINICAL_TRIALS trial_result · 2015-09-11Clinical Trial Update: Safety and Efficacy of Daclatasvir (BMS-790052) Plus Standard of Care in Japanese Patients (Pegylated-interferon Alpha-2a and Ribavirin) [Phase 2]
Phase 2 study evaluating daclatasvir with standard of care (pegylated interferon alfa-2a and ribavirin) in Japanese patients with Hepatitis …
-
CLINICAL_TRIALS trial_result · 2015-09-10Clinical Trial Update: A Single Ascending Dose Study of Daclatasvir (BMS-790052) in Hepatitis C Virus Infected Subjects [Phase 1, Phase 2]
A clinical trial update reporting results from a single ascending-dose study of Daclatasvir (BMS-790052) in chronic hepatitis C patients, co…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2015-09-09Clinical Trial Update: Safety and Tolerability of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin for the Treatment of Vietnamese Subjects With Chronic Hepatitis C Genotype 1 (P08599) [Phase 3]
Phase 3 clinical trial NCT01641666 evaluating the safety and tolerability of Boceprevir in combination with peginterferon alfa-2b plus ribav…
-
CLINICAL_TRIALS trial_result · 2015-09-07Clinical Trial Update: Phase III BMS-790052 Add-On to Peg-Interferon Alfa-2a and Ribavirin in Naive Hepatitis C [Phase 3]
Phase III trial evaluating BMS-790052 (daclatasvir) added to pegylated interferon alfa-2a and ribavirin in treatment-naive hepatitis C patie…
-
CLINICAL_TRIALS trial_result · 2015-09-07Clinical Trial Update: Short Term Treatment With BI 201335, Peginterferon-alpha 2a and Ribavirin in Hepatitis c Virus Genotype-1 Treatment-naïve Patients (SILEN-C3) [Phase 2]
A Phase 2 study (SILEN-C3) evaluated short-term treatment with BI 201335 in combination with peginterferon-alfa-2a and ribavirin in genotype…
-
CLINICAL_TRIALS trial_result · 2015-09-07Clinical Trial Update: Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody Testing
A completed clinical trial compared Plasma and SMARTplasma antibody tests for detecting HIV and Hepatitis C antibodies.
-
CLINICAL_TRIALS trial_result · 2015-09-04Clinical Trial Update: Phase III Trial of BI 201335 (Faldaprevir) in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)-Human Immunodeficiency Virus (HIV) Coinfected Patients (STARTverso 4) [Phase 3]
Phase III trial of faldaprevir in treatment-naive and relapser Hepatitis C patients co-infected with HIV has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2015-09-04Clinical Trial Update: Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Malignancy Other Than Hepatocellular Carcinoma [Phase 4]
Phase 4 trial evaluating pegylated interferon plus ribavirin in chronic hepatitis C patients with other malignancies (not hepatocellular car…
-
CLINICAL_TRIALS withdrawal · 2015-09-03Clinical Trial Update: Observational Prospective Registry of the Efficacy, Safety, and Adherence to Infergen® in Patients Infected With Hep C
A prospective observational registry evaluating Infergen (interferon alfacon-1) for Hepatitis C has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-09-02Clinical Trial Update: Treatment of Recently Acquired Hepatitis C Virus Infection [Phase 4]
This clinical trial report summarizes a Phase 4 study evaluating treatment for recently acquired Acute Hepatitis C; the study has completed.
-
CLINICAL_TRIALS trial_result · 2015-09-02Clinical Trial Update: Comparative Trial of Standard Versus Low-dose Peg-Interferon Plus Ribavirin in the Treatment of Chronic Hepatitis C
A completed comparative clinical trial evaluated standard-dose versus low-dose pegylated interferon plus ribavirin for chronic hepatitis C.
-
CLINICAL_TRIALS trial_result · 2015-09-02Clinical Trial Update: Low-dose Peg-interferon Plus Ribavirin (IFN/RBV) for Prevention of Hepatocellular Carcinoma (HCC) Recurrence in Patients Who Had Surgery to Remove Primary HCC [Phase 4]
Phase 4 clinical trial evaluating low-dose pegylated interferon plus ribavirin to prevent hepatocellular carcinoma recurrence after surgical…
-
FDA approval · 2015-08-19FDA Approved: SOVALDI — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for Sovaldi (sofosbuvir) submitted by Gilead Sciences.
-
CLINICAL_TRIALS trial_result · 2015-08-18Clinical Trial Update: Algeron (Cepeginterferon Alfa-2b) Compared With PegIntron (Peginterferon Alfa-2b) for Treatment of Chronic Hepatitis C [Phase 2, Phase 3]
A completed Phase 2/3 trial comparing Algeron (cepeginterferon alfa-2b) with PegIntron (peginterferon alfa-2b) for chronic hepatitis C, with…
-
CLINICAL_TRIALS research · 2015-08-17Clinical Trial Update: Pharmacogenomics Study on IL28B Genetic Variants in Chinese Children With Hepatitis C Virus Infection
A pharmacogenomics study exploring IL28B genetic variants in Chinese children with chronic Hepatitis C infection.
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: An Efficacy, Pharmacokinetics, Safety and Tolerability Study of TMC435 as Part of a Treatment Regimen for Hepatitis C-Infected Patients [Phase 3]
Phase 3 study results for TMC435 in a hepatitis C treatment regimen, reporting efficacy, pharmacokinetics, safety and tolerability.
-
CLINICAL_TRIALS trial_result · 2015-08-10Clinical Trial Update: Open Label Single Dose Phase I Trial of BI 201335 to Study Pharmacokinetics and Safety in Patients With Compensated Liver Cirrhosis [Phase 1]
Open-label Phase I single-dose pharmacokinetics and safety study of BI 201335 in patients with compensated liver cirrhosis and Hepatitis C; …
-
CLINICAL_TRIALS trial_result · 2015-08-07Clinical Trial Update: A Triple Combination Therapy Study of Boceprevir, Pegasys and Copegus in Previously Untreated Patients With Genotype 1 Chronic Hepatitis C [Phase 4]
A Phase 4 clinical trial evaluating a triple therapy of boceprevir, pegylated interferon alfa-2a (Pegasys) and ribavirin (Copegus) in previo…
-
CLINICAL_TRIALS trial_result · 2015-08-07Clinical Trial Update: Biliverdin Reductase A in Chronic Hepatitis C Virus Infection
A completed clinical trial at Charles University evaluated biliverdin reductase A in people with chronic hepatitis C infection.
-
CLINICAL_TRIALS trial_result · 2015-08-07Clinical Trial Update: Analysis of Host Genetic Factors in the Occurrence of Anemia and on the Virological Response to a Peg-interferon/Ribavirin Therapy in HIV-HCV Co-infected Patients [NA]
This completed clinical trial analyzed host genetic factors to understand anemia risk and virological response to Peg-interferon plus ribavi…
-
CLINICAL_TRIALS trial_result · 2015-08-05Clinical Trial Update: Hepatic Safety of Eviplera® in HIV/Hepatitis C (HCV)-Coinfected Patients Without HCV Treatment in the "The HEPAVIR HEPATIC SAFETY Cohort."
Completed cohort study evaluating the hepatic safety of Eviplera (rilpivirine/emtricitabine/tenofovir disoproxil fumarate) in HIV/HCV coinfe…
-
CLINICAL_TRIALS trial_result · 2015-08-04Clinical Trial Update: A Study to Evaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus Infection [Phase 2]
A Phase 2 study assessing safety and effect of combining ABT-450/r with ABT-267 in adults with chronic hepatitis C; study completed with res…